Literature DB >> 30736935

ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction: Medical and Surgical Interventions.

Deedra H Harrington1, Frances Stueben2, Christy McDonald Lenahan2.   

Abstract

Coronary artery disease is the leading cause of death in both men and women in the United States. Annually, 790,000 Americans will experience a myocardial infarction. Early recognition and appropriate management of myocardial infarction are imperative to improving patient outcomes. This article discusses the pathophysiology, presentation, and diagnosis and management of both ST-elevation myocardial infarction (STEMI) and non-STEMI.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary artery disease (CAD); NSTEMI; STEMI

Mesh：

Year:  2018        PMID： 30736935     DOI： 10.1016/j.cnc.2018.10.002

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN： 0899-5885            Impact factor:   1.326


  6 in total

1.  The Predictive Value of Barthel Score, Sequential Organ Failure Assessment Score, and D-Dimer in the 28-Day Prognosis of Patients with Non-ST Elevation Myocardial Infarction: A Retrospective Study of 358 Patients.

Authors:  GuiYing Dai; Jun Yang; JunYu Wang; FengLi Gao; WenHong Liu; Ping Li; Bing Wei
Journal:  Int J Gen Med       Date:  2022-09-13

2.  Relationship between Admission Electrolyte Level and Short-term Prognosis of Patients with Acute ST-segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.

Authors:  Yaping Ren; Zhijie Yue; Xuewen Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-09       Impact factor: 2.629

3.  17-estradiol nanoparticles influence inflammatory response of myocardial infarction possibly through downregulation of miR-302b.

Authors:  Hao Ma; Dong Xu; Fei Liu; Qing Yao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.

Authors:  Arash Gholoobi; Vahid Reza Askari; Hossein Naghedinia; Mostafa Ahmadi; Vida Vakili; Vafa Baradaran Rahimi
Journal:  Inflammopharmacology       Date:  2021-08-21       Impact factor: 4.473

Review 5.  Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches.

Authors:  César Daniel Sánchez-Hernández; Lucero Aidé Torres-Alarcón; Ariadna González-Cortés; Alberto N Peón
Journal:  Mediators Inflamm       Date:  2020-01-29       Impact factor: 4.711

6.  The association between anxiety disorders and in-hospital outcomes in patients with myocardial infarction.

Authors:  Pengyang Li; Xiaojia Lu; Mark Kranis; Fangcheng Wu; Catherine Teng; Peng Cai; Zeba Hashmath; Bin Wang
Journal:  Clin Cardiol       Date:  2020-03-18       Impact factor: 2.882
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.